Laser zap before eye injection could cut needle count for wet AMD
NCT ID NCT07744204
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This study tests whether a low-intensity laser applied to the diseased area just before an anti-VEGF injection helps the drug work better in people with wet age-related macular degeneration (AMD). Wet AMD causes abnormal blood vessels to leak fluid under the retina, and current treatment requires frequent eye injections. The trial will compare patients who receive laser plus injection versus injection alone, tracking how many injections are needed over 24 months. If the laser enhances drug delivery, patients may need fewer injections, reducing the burden of treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Laser photocoagulation (577-nm yellow laser) combined with anti-VEGF injections (conbercept, aflibercept, ranibizumab, or faricimab)
- What this could lead to
- If successful, this approach could reduce the number of eye injections needed for wet AMD, easing the treatment burden for patients.
- What could go wrong
- The trial is relatively small and early, and the laser may not enhance drug delivery as hoped. There are also risks of laser-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Time gene therapy tame wet AMD for years?
- Can a new eye injection save vision in wet AMD?
- Eye injection aims to tame leading causes of blindness
- New eye drug aims to save sight in wet AMD
- New eye injection shows promise for wet AMD in everyday practice
- New syringe could simplify High-Dose eye treatment